The United States and the United Kingdom reached a pharmaceutical pricing and trade agreement that raises NICE cost-effectiveness thresholds by 25% and eliminates tariffs on medicine imports between the two countries. The UK committed to increasing NICE’s cost-effectiveness range from
The Trump administration is preparing to launch a new investigation into foreign nations’ drug pricing practices that could pave the way for additional U.S. tariffs on pharmaceutical imports. The probe, expected to be led by the Office of the U.S.
AstraZeneca has become the second major pharmaceutical manufacturer to sign a “most favored nation” pricing agreement with the Trump administration, committing to match the lowest drug prices offered in developed nations for Medicaid programs and newly launched products. President Donald
The UK government has developed proposals to increase NHS spending on pharmaceuticals by 15-25%, according to multiple reports, as officials attempt to resolve an escalating standoff with the pharmaceutical industry while simultaneously preparing for potential US tariffs under President Trump’s
